Outcome of Childhood Transverse Myelitis and Association with Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

• Conditions: transverse myelitis; children, transverse myelitis, prognostic factor, anti-MOG, neuromyelitis optica, NMO, NMOSD

• Registration Number: TCTR20210521006
• Lead Sponsor: Faculty of Medicine Ramathibodi Hospital, Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-21
• Study Completion: 2022-04-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients aged under 15 years with confirmed diagnosis of acute transverse myelitis and follow-up time over a period of 6 months between January 2000 to August 2021 in Ramathibodi Hospital

Exclusion Criteria

histories of post spinal radiation, spinal vascular malformation, thrombosis of spinal artery, infectious myelitis

Study & Design

• Study Type: Observational
• Study Design: Not specified